These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 18422846)
1. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Gonzalez-Porras JR; Graciani IF; Perez-Simon JA; Martin-Sanchez J; Encinas C; Conde MP; Nieto MJ; Corral M Transfusion; 2008 Jul; 48(7):1318-24. PubMed ID: 18422846 [TBL] [Abstract][Full Text] [Related]
2. Anti-D alloimmunization after transfusion of D+ red blood cells. Cid J; Ramiro L Transfusion; 2009 Jan; 49(1):186-7; author reply 187. PubMed ID: 19140813 [No Abstract] [Full Text] [Related]
3. Detection of anti-D in D- recipients transfused with D+ red blood cells. Yazer MH; Triulzi DJ Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422 [TBL] [Abstract][Full Text] [Related]
4. Secondary anti-D immunization by Del red blood cells. Yasuda H; Ohto H; Sakuma S; Ishikawa Y Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208 [TBL] [Abstract][Full Text] [Related]
5. Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization. Yazer MH; Triulzi DJ Am J Clin Pathol; 2010 Sep; 134(3):443-7. PubMed ID: 20716801 [TBL] [Abstract][Full Text] [Related]
6. Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Arslan O; Toprak S; Arat M; Kayalak Y Transfusion; 2004 Apr; 44(4):485-8. PubMed ID: 15043562 [TBL] [Abstract][Full Text] [Related]
7. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. Saied DA; Kaddah AM; Badr Eldin RM; Mohaseb SS J Pediatr Hematol Oncol; 2011 Aug; 33(6):409-14. PubMed ID: 21792035 [TBL] [Abstract][Full Text] [Related]
8. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180 [TBL] [Abstract][Full Text] [Related]
9. Anti-AnWj causing acute hemolytic transfusion reactions in a patient with aplastic anemia. Xu Z; Duffett L; Tokessy M; Cote J; Goldman M; Saidenberg E Transfusion; 2012 Jul; 52(7):1476-81. PubMed ID: 22233405 [TBL] [Abstract][Full Text] [Related]
10. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. Schonewille H; Brand A Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967 [TBL] [Abstract][Full Text] [Related]
11. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Yazer MH; Triulzi DJ; Shaz B; Kraus T; Zimring JC Transfusion; 2009 Jun; 49(6):1070-5. PubMed ID: 19309468 [TBL] [Abstract][Full Text] [Related]
12. A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. Reikvam H; Prowse C; Roddie H; Heddle NM; Hervig T; Vox Sang; 2010 Jul; 99(1):71-6. PubMed ID: 20230596 [TBL] [Abstract][Full Text] [Related]
13. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. Friese RS; Sperry JL; Phelan HA; Gentilello LM Am J Surg; 2008 Jul; 196(1):56-61. PubMed ID: 18513694 [TBL] [Abstract][Full Text] [Related]
14. Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin. Nester TA; Rumsey DM; Howell CC; Gilligan DM; Drachman JG; Maier RV; Kyles DM; Matthews DC; Pendergrass TW Transfusion; 2004 Dec; 44(12):1720-3. PubMed ID: 15584986 [TBL] [Abstract][Full Text] [Related]
15. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Schonewille H; van de Watering LM; Brand A Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440 [TBL] [Abstract][Full Text] [Related]
16. Alloimmunization to red cell antigens in liver and multivisceral transplant patients. Shariatmadar S; Pyrsopoulos NT; Vincek V; Noto TA; Tzakis AG Transplantation; 2007 Aug; 84(4):527-31. PubMed ID: 17713438 [TBL] [Abstract][Full Text] [Related]
17. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623 [TBL] [Abstract][Full Text] [Related]
18. Red cell immunization in multiply transfused Malay thalassemic patients. Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748 [TBL] [Abstract][Full Text] [Related]
19. [Alloimmunization in polytransfused patients. Usefulness of selecting erythrocytes compatible with antigens different from ABO and D]. García Gala JM; Vargas Pabon M; Rodríguez Vicente P; Ramírez Payer A; Rosón Porto C; Corte Buelga JR Sangre (Barc); 1994 Dec; 39(6):417-21. PubMed ID: 7855692 [TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Arndt PA; Garratty G Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]